Prenetics Global (NASDAQ:PRE) is a biotechnology company deeply engaged in revolutionizing the health and wellness industry through personalized diagnostics and genetics testing. With a focus on providing actionable insights for individuals to make informed health decisions, Prenetics operates across multiple sectors including: digital health, precision medicine, and disease prevention. The company's projects range from COVID-19 testing solutions, which gained significant attention during the pandemic, to developing at-home genetic tests that assess risks for certain diseases and conditions. Prenetics aims to democratize access to health data, empowering people globally to take control of their health outcomes with cutting-edge technology and science-backed solutions.